Academia has a spotty track record when it comes to drug development. They don't have the money to put into lots of potential drugs, so they aren't able to test the breadth of targets that a Bayer would be able to. For all of the problems that Pharma has, they have been able to bring a lot of new drugs to market pretty efficiently.